|
|
|
Gene Therapy |
|
R. Jude Samulski: Gene Therapy’s Guiding Force
|
Chronicling the career “trek” of gene therapy visionary R. Jude Samulski, whose work uncovering the mysteries of adeno-associated virus while navigating the field’s reputational turbulence continues to fuel new hopes for AAV vector technology in transforming therapies for rare disease.
... /Read more/
|
|
|
Advertisement |
Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
On Demand
|
Digital Strategy |
|
A Meaningful Customer-Centric Digital Strategy
|
Data is fast becoming the most valuable commodity known to man. As an infinite resource with evolving applications, the pace at which organizations can acquire, manage the flow of, and leverage data is becoming a crucial factor in the future success of businesses, write Pamela Walker and Tom Murdoch.
... /Read more/
|
|
|
Advertisement |
Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
On Demand
|
|
|
Pipeline Report |
|
Pharm Exec’s 2020 Pipeline Report
|
Our Annual Pipeline Report examines six key areas of biopharma R&D—a mix of emerging and maturing—where promising research efforts are now beginning to pay dividends, as novel advances in science usher in new treatment approaches and curative therapies.
... /Read more/
|
|
|
The Pharm Exec Podcast: Episode 45 |
|
Sponsored by Fingerpaint
|
Getting Drug Approval Through FDA LPAD
|
William Lewis, chairman and CEO of Insmed talks about the approval of the company’s drug Arikayce through the FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs, some ideas that he spoke about on the recent NORD panel about innovative and ethical partnerships, and Insmed’s pipeline and progress.
... /Read more/
|
|
|
|
|
|
|